Analysis: Tysabri won`t top current drugs

Monsters and Critics.com - Glasgow,UK
WASHINGTON, DC, United States (UPI) -- The Food and Drug Administration`s approval of Biogen Idec`s multiple-sclerosis treatment Tysabri to return to the ...

Elan Shares Fall on US Plan for Tysabri Return (Update2)
Bloomberg - USA
shares plunged after US regulators yesterday said the multiple sclerosis drug Tysabri should be limited to patients who weren't helped by rival treatments when ...

US watchdog backs Tysabri return
RTE.ie - Ireland
US regulatory authorities have approved the resumption of sales of Elan's multiple sclerosis drug Tysabri. The drug had been withdrawn ...

Elan's MS drug Tysabri to return to market; Shares fall by 12% on ...
FinFacts Ireland - Ireland
... firm Elan Corporation on Monday announced the approval by the US Food and Drug Administration (FDA) for the reintroduction of its Tysabri (natalizumab) drug ...

Elan rises as price raised on Tysabri
BusinessWeek - USA
... PLC gained some lift Friday after the Irish drug maker set the price for its multiple sclerosis treatment Tysabri as much as 26 percent higher than some ...
See all stories on this topic

FDA OKs Limited Use of Tysabri
Los Angeles Times - CA,USA
WASHINGTON — US health officials cleared the way Monday for multiple sclerosis drug Tysabri to return to the market with restrictions, after its withdrawal ...

Elan secures restricted Tysabri approval
Ireland Online - Dublin,Ireland
... quoted Biogen Idec have been given restricted approval by the US Food and Drug Administration (FDA) for the reintroduction of multiple sclerosis drug Tysabri. ...

US officials clear way for Tysabri return
RTE.ie - Ireland
Health officials in the United States have cleared the way for the Multiple Sclerosis drug Tysabri to return to the market. The ...